PBE
PBE
About Invesco Biotechnology & Genome ETF
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings...
About Invesco Biotechnology & Genome ETF
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ILMN | Illumina, Inc. | 5.63% | 102.29K | $15.36M |
 REGN | Regeneron Pharmaceuticals, Inc. | 5.03% | 16.92K | $13.74M |
 BIIB | Biogen Inc. | 4.99% | 72.86K | $13.62M |
 UTHR | United Therapeutics Corporation | 4.98% | 27.00K | $13.60M |
 INCY | Incyte Corporation | 4.91% | 121.27K | $13.41M |
 AMGN | Amgen Inc. | 4.82% | 38.54K | $13.17M |
 GILD | Gilead Sciences, Inc. | 4.69% | 102.85K | $12.79M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 4.59% | 29.67K | $12.54M |
 FOLD | Amicus Therapeutics, Inc. | 3.72% | 710.58K | $10.16M |
 DVAX | Dynavax Technologies Corporation | 3.47% | 614.30K | $9.47M |
 BCRX | BioCryst Pharmaceuticals, Inc. | 2.99% | 1.03M | $8.15M |
 ACAD | ACADIA Pharmaceuticals Inc. | 2.95% | 294.04K | $8.06M |
 MNKD | MannKind Corporation | 2.94% | 1.37M | $8.01M |
 BMRN | BioMarin Pharmaceutical Inc. | 2.84% | 126.62K | $7.76M |
 EXEL | Exelixis, Inc. | 2.81% | 166.33K | $7.68M |
 IONS | Ionis Pharmaceuticals, Inc. | 2.73% | 89.50K | $7.44M |
 RPRX | Royalty Pharma plc | 2.68% | 176.79K | $7.32M |
 VCEL | Vericel Corporation | 2.67% | 180.75K | $7.29M |
 COLL | Collegium Pharmaceutical, Inc. | 2.67% | 154.20K | $7.29M |
 TECH | Bio-Techne Corporation | 2.64% | 110.69K | $7.20M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
NetherlandsSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States NetherlandsHoldings (Top 20)
ILMN
Illumina, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
BIIB
Biogen Inc.
UTHR
United Therapeutics Corporation
INCY
Incyte Corporation
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
FOLD
Amicus Therapeutics, Inc.
DVAX
Dynavax Technologies Corporation
BCRX
BioCryst Pharmaceuticals, Inc.
ACAD
ACADIA Pharmaceuticals Inc.
MNKD
MannKind Corporation
BMRN
BioMarin Pharmaceutical Inc.
EXEL
Exelixis, Inc.
IONS
Ionis Pharmaceuticals, Inc.
RPRX
Royalty Pharma plc
VCEL
Vericel Corporation
COLL
Collegium Pharmaceutical, Inc.
TECH
Bio-Techne Corporation